During the past decade, Department of Anesthesiology and Intensive Care, University Hospital Münster conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Anesthesiology and Intensive Care, University Hospital Münster" #1 sponsor was "University Hospital Muenster" with 6 trials, followed by "BeiGene" with 2 trials sponsored, "Ionis Pharmaceuticals, Inc." with 2 trials sponsored, "Kompetenznetz Sepsis" with 2 trials sponsored and "Heinrich-Heine University, Duesseldorf" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Anesthesiology and Intensive Care, University Hospital Münster" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Biosyn" with 1 trials as a collaborator, "Brahms AG" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Department of Anesthesiology and Intensive Care, University Hospital Münster" are "Amyloidosis" (2 trials), "FAP" (2 trials), "Familial Amyloid Polyneuropathy" (2 trials), "Septic Shock" (2 trials) and "Severe Sepsis" (2 trials). Many other conditions were trialed in "Department of Anesthesiology and Intensive Care, University Hospital Münster" in a lesser frequency.

Most popular intervention types in "Department of Anesthesiology and Intensive Care, University Hospital Münster" are "Drug" (11 trials), "Procedure" (4 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Inotersen" (2 trials), "Nivolumab" (2 trials), "No intervention" (2 trials), "Placebo" (2 trials) and "BGB-3111" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Anesthesiology and Intensive Care, University Hospital Münster" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Department of Anesthesiology and Intensive Care, University Hospital Münster". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Department of Anesthesiology and Intensive Care, University Hospital Münster, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Anesthesiology and Intensive Care, University Hospital Münster, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".